CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
Propranolol +1 moredrug
Likely dose
Propranolol 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01055171
NCT01055171Phase 2Completed
CompareCT.gov

Treatment Implications of Trauma Memory Modulation for PTSD & Alcohol Dependence

Medical University of South Carolina·interventional·Posted Jan 25, 2010·Updated Mar 8, 2016

In Brief

A Phase 2 clinical trial evaluating Propranolol and Placebo for Alcohol Dependence and PTSD. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the effect of propranolol versus placebo on craving, distress and cue reactivity to trauma and alcohol cues.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Dependence, PTSD
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 25, 2010
Enrollment StartJan 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 16.4 years ago

Interventions

Propranololdrug

40 mg; Single Administration.

Placebodrug

40 mg; Single Dose.